Biogen Pharmachem Industries (BSE: BIOGEN) is loss-making over the last 12 months, losing ₹0.26 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹0.26, 64% below its 52-week high. Sales fell 2.8% a year over 3 years. It is a small-cap company with a market cap of ₹27 Cr, ranked 142nd of 219 Capital Markets companies by market cap; the shares fell 63% over the past year.
- ₹0.26
- ₹0.27
- ₹0.25
- ₹0.26
- 27.9 L
Health check
- ReturnsBehind
−62.6% over a year, better than 0 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales −2.8%, profit +23.6% a year over 3 years, but loss-making now.
- ProfitabilityWeak
ROCE 1.0% vs peer median 22.1%.
- Balance sheetFair
Piotroski 5 of 9.
- Red flags5 to check
Loss-making over the last twelve months.
Small cap
Defensive
Key metrics
- Market cap
- ₹27 Cr
- Small cap
- P/E
- n/a
- Industry 18.4
- Price to book
- 0.24
- Peers 4.53
- Dividend yield
- 0.00%
- ROE
- 0.9%
- Peers 18.9%
- ROCE
- 1.0%
- Peers 22.1%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- ₹0.00
- OPM (TTM)
- 49.9%
- Net margin −18.1%
- Sales growth
- −71.3%
- Latest quarter vs a year ago
- Profit growth
- −83.5%
- Latest quarter vs a year ago
- Price to sales
- 18.77
Strengths and risks
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at 0.9%.
- Quarterly profit down 83.5% on a year ago.
- Quarterly sales down 71.3% on a year ago.
- 64% below its 52-week high.
About Biogen Pharmachem Industries
Biogen Pharmachem Industries Limited engages in the trading of shares and securities in present and future market. The company was formerly known as Sun Techno Overseas Limited and changed its name to Biogen Pharmachem Industries Limited in March 2021. Biogen Pharmachem Industries Limited was incorporated in 1995 and is based in Rajkot, India.
- Headquarters
- Rajkot
- Sector
- Financial Services
- ISIN
- INE703D01023
- Website
- biogenpharma.bar
Price range
- Avg volume (3M)
- 46.1 L
- 1-year return
- minus 62.6%
- From 52-week high
- minus 63.9%
Peers · Capital Markets
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GROWWBillionbrains Garage Ventures | 215.08 | minus 3.93% | 1,33,585 | 50.3 | 13.78 | 29.3% | 21.6% | 62.9% | – | – | 0.00% | plus 63.8% |
| MOTILALOFSMotilal Oswal Financial Services | 1,102.00 | plus 0.64% | 66,448 | 25.0 | 4.27 | 18.1% | 18.9% | 52.4% | 29.0% | 26.1% | 0.54% | plus 11.1% |
| AIILAuthum Investment & Infrastructure | 570.05 | plus 0.08% | 48,410 | 27.6 | 3.29 | 15.2% | 13.1% | 74.0% | 44.4% | −23.5% | 0.00% | minus 0.7% |
| ANGELONEAngel One | 331.00 | plus 1.49% | 30,290 | 26.8 | 4.53 | 26.9% | 18.4% | 39.7% | 20.3% | 0.9% | 1.95% | plus 29.5% |
| CDSLCentral Depository Services (India) | 1,331.40 | minus 0.19% | 27,826 | 55.1 | 14.03 | 29.7% | 26.4% | 51.3% | 27.3% | 18.2% | 0.96% | minus 13.3% |
| CHOICEINChoice International | 748.20 | minus 0.09% | 16,668 | 62.9 | 8.90 | 17.6% | 15.8% | 35.3% | 42.2% | 53.6% | 0.00% | minus 7.4% |
| IIFLCAPSIIFL Capital Services | 349.80 | plus 0.13% | 13,036 | 18.8 | 3.15 | 22.1% | 19.5% | 36.1% | 19.9% | 30.9% | 0.86% | plus 4.1% |
| BIOGENBiogen Pharmachem Industries | 0.26 | 0.00% | 27 | – | 0.24 | 1.0% | 0.9% | 49.9% | −2.8% | 23.6% | 0.00% | minus 62.6% |
| Median of 7 peers | – | 0.08% | 30,290 | 27.6 | 4.53 | 22.1% | 18.9% | 51.3% | 28.2% | 22.2% | 0.54% | 4.1% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 1.3 | −0.4 | −0.1 | −0.4 | 0.2 | |
| 0 | −0.1 | 0.5 | 0 | 0 | |
| 1.3 | −0.5 | 0.5 | −0.4 | 0.2 | |
| 1.3 | −0.5 | 0.5 | −0.4 | 0.2 | |
| 0.01 | -0.01 | 0.01 | – | – |
Profit & loss
- Sales CAGR 3Y
- −2.8%
- Profit CAGR 3Y
- +23.6%
- EPS CAGR 3Y
- 0.0%
- ROE
- 0.9%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.7 | – | −0.4 | 0.6 | |
| 0.5 | – | 1.1 | 1 | |
| 0.2 | 1.9 | −1.5 | −0.4 | |
| 31.3% | – | 416.6% | −57.6% | |
| 0.2 | 0 | 1.2 | 1.9 | |
| – | – | – | −0.6 | |
| 0.5 | 1.9 | −0.3 | 1 | |
| – | – | – | 10.2% | |
| 0.5 | 1.9 | −0.3 | 0.9 | |
| – | +323.9% | minus 115.2% | – | |
| 0.01 | 0.03 | – | 0.01 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 65.3 | 65.3 | 65.3 | 90.3 | |
| −10.7 | −8.7 | 26.7 | 8.8 | |
| 0.2 | 0.3 | 0.1 | 0.3 | |
| 54.8 | 56.8 | 92 | 99.4 | |
| 8.9 | 5.4 | 15.1 | 24.1 | |
| 0.1 | 0 | 2 | 0.3 | |
| 45.8 | 51.4 | 74.9 | 75 | |
| 54.8 | 56.8 | 92 | 99.4 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.7 | 1.9 | −1.1 | 1.6 | |
| −1.7 | −2.1 | −32.6 | −9.6 | |
| – | – | 35.7 | 6.3 | |
| 0 | −0.1 | 2 | −1.7 | |
| 1.7 | 1.9 | −1.1 | 1.6 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.